Miroculus raises $45M in extended series B financing

Laboratory automation firm Miroculus that it has completed a Series B financing extension bringing the total capital raised in the round to $45 million.

San Francisco-based Miroculus said that it will use the financing primarily to build out its commercial team and expand a beta program supporting a full commercial launch, originally planned for last year, of its first platform, the Miro Canvas sample prep system.

The Miro Canvas uses digital microfluidics to automate complex processes such as next-generation sequencing library prep in a compact, cartridge-based system. The company unveiled the platform last year at the Advances in Genome Biology and Technology annual meeting.